Riskpilot← Back to searchSign inGet full accessFROGNER APOTEK SØRUM AS
ASActiveOrg 997958411Frognerveien 2, 2016 FrognerRetail sale of pharmaceutical products · NACE 4773Est. 201212 employees
Revenue 2024
NOK 19,8M
+9% vs 2023
EBITDA margin
6.3%
+72% vs 2023
Equity ratio
29.0%
Financial strength
Net profit 2024
NOK 994K
+30% vs 2023
| Revenue | NOK 19,8M | +9% |
| EBITDA | NOK 1,3M | +72% |
| Net profit | NOK 994K | +30% |
| Total assets | NOK 4,5M | -30% |
| Equity | NOK 1,3M | +24% |
| Employees | 12 | — |
Legal name
FROGNER APOTEK SØRUM AS
Org number
997958411
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
10. februar 2012
Share capital
NOK 1 300 000
Employees
12 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap. Styrets leder og ett styremedlem i fellesskap.
Company purpose
Selskapets formål er å eie og drive apotek og alt hva hermed står i forbindelse
Address
Frognerveien 2, 2016 Frogner
Phone
+4763820015
Email
dittapotek.frogner.sorum@apotek.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 14 414 | 14 967 | 14 784 | 18 187 | 19 785 |
| Staff expenses | −2 589 | −2 578 | −2 801 | −2 809 | −2 675 |
| EBITDA | 218 | 136 | −18 | 727 | 1 253 |
| Depreciation & amort. | −53 | −53 | −53 | −54 | −65 |
| EBIT | 166 | 83 | −70 | 673 | 1 188 |
| Net financials | −6 | −4 | −0 | 21 | 87 |
| Profit before tax | 160 | 79 | −71 | 694 | 1 275 |
| Tax | −0 | −0 | −0 | −69 | 280 |
| Net profit | 160 | 79 | −71 | 763 | 994 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 236 | 2 510 | 2 335 | 6 448 | 4 503 |
| Equity | 280 | 360 | 289 | 1 052 | 1 307 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 956 | 2 150 | 2 046 | 5 396 | 3 197 |
| Total debt | 1 956 | 2 150 | 2 046 | 5 396 | 3 197 |
EBITDA margin
6.3%
This company
15.8%
Market median
-60% vs market
20202024
Equity ratio
29.0%
This company
38.2%
Market median
-24% vs market
20202024
Return on equity
76.1%
This company
18.4%
Market median
+314% vs market
20202024
Net profit margin
5.0%
This company
8.1%
Market median
-38% vs market
20202024
Asset turnover
4.39×
This company
1.12×
Market median
+292% vs market
20202024
Debt / equity
2.45×
This company
0.62×
Market median
-295% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AB Chief Executive Officer | Chief Executive Officer | 2012 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2023 | |
| Former (2) | ||
| Chairman | 2012 – 2023 | |
| Board of Directors | 2012 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 50% | 50% | 2024 | |
| Company | 25% | 25% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Fraunar As
FROGNER APOTEK SØRUM AS Board members of FROGNER APOTEK SØRUM AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anders Brekke | Chief Executive Officer | 0 companies |
| Morten Frogner | Chairman | 0 companies |
| Jan Arne Frogner | Board of Directors | 0 companies |
| Einar Mathias Teigen Rasch-Halvorsen | Chairman | 0 companies |